These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3501412)

  • 1. IgG from Epstein-Barr virus infectious mononucleosis patients inhibits interleukin-2 production.
    Sundar SK; Stefanescu I; Menezes J
    Int J Immunopharmacol; 1987; 9(8):869-73. PubMed ID: 3501412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprinosine abolishes the blocking factor-mediated inhibition of lymphocyte responses to Epstein-Barr virus antigens and phytohemagglutinin.
    Sundar SK; Menezes J
    Int J Immunopharmacol; 1986; 8(1):101-6. PubMed ID: 2420730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunity in infectious mononucleosis: I. Spontaneous and phytohaemagglutinin-induced blast transformation in infectious mononucleosis, with special reference to depressed cellular reactivity and stimulation-blocking serum factors.
    Nikoskelainen J; Stevens DA; Neel EU; Isenberg RA; Miller RG; Halpern JW; Gelpi AP
    IARC Sci Publ (1971); 1978; (24 Pt 2):699-709. PubMed ID: 751903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
    Yanagisawa M; Kato M; Ikeno K; Kobayashi T; Miyagawa Y; Komiyama A; Akabane T
    Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T lymphocytes in infectious mononucleosis; effect of IL-2 on the outgrowth of Epstein-Barr virus-infected cells.
    Misko IS; Burrows SR; Schmidt C; Bishop CJ; Ryan JM; Staples JA; Moss DJ
    Immunol Cell Biol; 1989 Feb; 67 ( Pt 1)():49-55. PubMed ID: 2785955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters.
    Nikoskelainen J; Ablashi DV; Isenberg RA; Neel EU; Miller RG; Stevens DA
    J Immunol; 1978 Oct; 121(4):1239-44. PubMed ID: 81224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An analysis of immunophenotyping of peripheral lymphocytes in adult patients with infectious mononucleosis and chronic active Epstein-Barr virus infection].
    Xie J; Wang HL; Qiu ZF; Li TS
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):455-9. PubMed ID: 27256608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein.
    Kakalacheva K; Regenass S; Wiesmayr S; Azzi T; Berger C; Dale RC; Brilot F; Münz C; Rostasy K; Nadal D; Lünemann JD
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26907324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the serological diagnosis of Epstein-Barr virus among patients with mononucleosis].
    Liu CY; Yan J; Liu YY; Xie ZD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Sep; 28(9):898-900. PubMed ID: 18251276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Th1-type cytokine serum levels in patients with infectious mononucleosis.
    Corsi MM; Ruscica M; Passoni D; Scarmozzino MG; Gulletta E
    Acta Virol; 2004; 48(4):263-6. PubMed ID: 15745050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ; McAulay KA; Anthony IC; Crawford DH
    J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.
    Weiss ER; Alter G; Ogembo JG; Henderson JL; Tabak B; Bakiş Y; Somasundaran M; Garber M; Selin L; Luzuriaga K
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27733645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appearance and some unusual features of Epstein-Barr virus antibody production in infectious mononucleosis and other health disorders.
    Stancek D; Kotuliaková M; Hrúzik J
    Acta Virol; 1977 Jan; 21(1):45-56. PubMed ID: 15437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
    Andersson J
    Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infectious mononucleosis].
    Yoneyama A
    Rinsho Byori; 2001 Oct; 49(10):996-9. PubMed ID: 11769479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection.
    Chijioke O; Müller A; Feederle R; Barros MH; Krieg C; Emmel V; Marcenaro E; Leung CS; Antsiferova O; Landtwing V; Bossart W; Moretta A; Hassan R; Boyman O; Niedobitek G; Delecluse HJ; Capaul R; Münz C
    Cell Rep; 2013 Dec; 5(6):1489-98. PubMed ID: 24360958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocyte anergy during acute infectious mononucleosis is restricted to the clonotypic receptor activation pathway.
    Pérez-Blas M; Regueiro JR; Ruiz-Contreras JR; Arnaiz-Villena A
    Clin Exp Immunol; 1992 Jul; 89(1):83-8. PubMed ID: 1628427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell mediated immunity during infectious mononucleosis to Epstein-Barr virus associated antigens.
    Periman P; Levine PH; Ablashi DV; Royston I
    Int J Cancer; 1977 Oct; 20(4):506-11. PubMed ID: 199544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.